Annexon Inc
(NAS:ANNX)
$
5.39
0.05 (0.94%)
Market Cap: 574.54 Mil
Enterprise Value: 264.03 Mil
PE Ratio: 0
PB Ratio: 1.72
GF Score: 40/100 Annexon Inc at Bank of America Healthcare Conference Transcript
May 12, 2022 / 03:40PM GMT
Release Date Price:
$3.29
(+9.67%)
Leon Wang
BofA Securities, Inc. - Analyst
(audio in progress) joining. My name is Leon Wang, one of Tazeen Ahmad's associate. It is my pleasure to introduce you all to Douglas Love, CEO of Annexon. Doug, pleasure to have you.
Douglas Love
Annexon, Inc. - President & CEO
Thanks for having us. We are really happy to be here this morning.
Questions & Answers
Leon Wang
BofA Securities, Inc. - Analyst
Great, great. So for those who may not be as familiar with the Annexon story, can you give us an overview of the technology? What's in your pipeline?
Douglas Love
Annexon, Inc. - President & CEO
Yeah, absolutely. So Annexon is focused on complement and specifically, the classical pathway, one of the three components of the complement system.
And what our thesis is that by blocking C1q in the classical pathway, we are providing more complete protection against aberrant complement activity.
So in a nutshell, in indications or diseases
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot